Background: Papillary thyroid cancer (PTC) has the highest cancer incidence in Korea. It is
known that some thyroid cancers have aggressive clinical behavior and a poor prognosis …

Simple Summary TERT promoter mutation has recently emerged as a promising prognostic
biomarker for aggressive papillary thyroid cancer (PTC), along with BRAF B600E mutation …

Background: Transcriptional activating mutations of telomerase reverse transcriptase (TERT)
are associated with more aggressive thyroid cancer. We evaluated the significance of TERT …

Background The prognostic value of the telomerase reverse transcriptase (TERT) promoter
mutation, resulting in poor clinical outcomes of papillary thyroid carcinoma (PTC), has been …

Objective Mutations in the telomerase reverse transcriptase (TERT) promoter have been
reported as a convincing prognostic factor in papillary thyroid carcinomas (PTCs). We aimed …

Background: The role of telomerase reverse transcriptase (TERT) promoter mutations in
differentiated thyroid cancer has been well established. These mutations have a significantly …

Context TERT promoter mutations have been associated with adverse prognosis in papillary
thyroid carcinomas (PTC s). Objective We investigated the association between TERT …

We performed a meta-analysis to elucidate the associations of the clinicopathological
characteristics and prognostic factors of papillary thyroid cancer (PTC) with TERT promoter …

We have read the article by Yang et al.[1] with great interest. They investigated real-world
frequencies of telomerase reverse transcriptase (TERT) promoter mutations (C228T [chr5 …

Background The BRAF V600E and telomerase reverse transcriptase (TERT) promoter
mutations have been reported in papillary thyroid carcinoma (PTC). The aim of this …